Product Specifications
| Catalog Number | BIC-0594E |
|---|---|
| Target | Transforming growth factor beta 2 |
| Target Symbol | TGFB2 |
| Species | Human |
| Expression System | CHO |
| Expression Region | Ala 303-Ser 414 |
| Molecular Weight | 12.7 kDa |
| Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Formulation | Lyophilized |
| Buffer | 0.085% TFA, 30% ACN, 5% Mannitol, pH 2.5 |
| Reconstitution | It is recommended to redissolve in 4 mM HCL. |
| Storage & Stability | 36 months at-20°C to -80°C in lyophilized state; 6 months at -20°C to -80°C under sterile conditions after reconstitution; 7-10 days at 2°C to 8°C under sterile conditions after reconstitution; Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping | The product is shipped with blue ice. |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Accession | P61812 |
| Alternative Names | Transforming growth factor beta-2; TGFB2; Polyergin; G-TSF; Glioblastoma-derived T-cell suppressor factor; Cetermin; BSC-1 cell growth inhibitor; TGF-beta-2 |
Bioactivity
Measured in a cell inhibition assay using TF-1 cells at IL4 presence. The ED50 for this effect is ≤0.3 ng/mL.
Quality Data
Recombinant Human TGF-β2 (Cat. No. BIC-0594E) was analyzed by SDS-PAGE.
Highly consistent bioactivity between different production batches of Recombinant Human TGF-β2 (Cat. No. BIC-0594E) .
